Soleno Therapeutics (NASDAQ:SLNO) just reported results for the first quarter of 2024.
- Soleno Therapeutics reported earnings per share of -59 cents. This was below the analyst estimate for EPS of -37 cents.
- The company did not report any revenue for the quarter.